| Quantitative particle agglutination assay for point-of-care testing using mobile holographic imaging and deep learning Y Luo, HA Joung, S Esparza, J Rao, O Garner, A Ozcan Lab on a Chip 21 (18), 3550-3558, 2021 | 21 | 2021 |
| Rosace: a robust deep mutational scanning analysis framework employing position and mean-variance shrinkage J Rao, R Xin, C Macdonald, MK Howard, GO Estevam, SW Yee, M Wang, ... Genome Biology 25 (1), 1-22, 2024 | 3 | 2024 |
| dotears: Scalable, consistent DAG estimation using observational and interventional data A Xue, J Rao, S Sankararaman, H Pimentel arXiv preprint arXiv:2305.19215, 2023 | 1 | 2023 |
| IMMU-13. PROMOTER DEMETHYLATION OF NY-ESO-1 PRIMES GLIOBLASTOMA FOR IMMUNOTHERAPEUTIC TARGETING T Lai, J Treger, J Rao, L Sun, T Li, A Lai, R Prins, RG Everson Neuro-Oncology 24 (Suppl 7), vii133, 2022 | | 2022 |
| Quantitative particle agglutination assay using mobile holographic imaging and neural networks Y Luo, HA Joung, S Esparza, J Rao, O Garner, A Ozcan CLEO: Applications and Technology, ATh2I. 5, 2022 | | 2022 |
| Quantitative particle agglutination assay for point-of-care sensing using mobile holographic imaging and neural networks Y Luo, HA Joung, S Esparza, J Rao, O Garner, A Ozcan Optics and Biophotonics in Low-Resource Settings VIII, PC1195004, 2022 | | 2022 |
| IMMU-30. IDENTIFICATION OF COORDINATELY REGULATED IMMUNO-MODULATORY GENES USING SINGLE-CELL RNA SEQUENCING OF DECITABINE TREATED GLIOMA CELLS T Lai, J Treger, J Rao, R Prins, R Everson Neuro-Oncology 23 (Suppl 6), vi99, 2021 | | 2021 |
